Despite the extensive pharmacology of NMDA receptors, the use of drugs able to decrease their overactivation in CNS pathologies is limited. One reason for this may be lack of knowledge of the effects of NMDA receptor antagonists on the functional properties of neurons, as a significant quantity of data has been obtained in in vitro models, which do not completely reproduce real pathophysiological processes. The present study addressed the effects of NMDA receptor antagonists with different mechanisms of action on the properties of pyramidal neuron responses in the prefrontal cortex of the rat brain. The competitive antagonist APV (50 μM) and the ion channel blocker memantine (100 μM) were inactive against evoked EPSP. In conditions of suppression of inhibitory transmission with picrotoxin (50 μM), extracellular stimulation evoked epileptiform responses with prolonged membrane depolarization and generation of a burst of action potentials. APV limited the duration and amplitude of these responses. Memantine acquired activity only when magnesium was excluded from the extracellular medium. Memantine’s lack of effect can be explained in terms of competition for the magnesium ion binding site in the channel cavity. These studies show that prediction of the systemic effects of blockers on neuron function and excitability requires use of in vitro models in which NMDA receptors are activated in the presence of a physiological magnesium concentration and without clamping of the membrane potential.
Read full abstract